Stay updated on Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Sign up to get notified when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision history now includes v3.5.0; the v3.4.3 entry was removed.
    Difference
    0.1%
    Check dated 2026-03-19T20:42:42.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The history now shows Revision: v3.4.3 and no longer lists Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-12T17:59:42.000Z thumbnail image
  4. Check
    24 days ago
    No Change Detected
  5. Check
    45 days ago
    Change Detected
    Summary
    A new site-wide revision entry (Revision: v3.4.2) was added to the history, and an older notice (Revision: v3.4.1) was removed; no study-specific content appears to be affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T09:22:20.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    A new site notice about government funding is now shown, and the release note Revision: v3.4.1 was added. The previous Revision: v3.4.0 was removed.
    Difference
    0.7%
    Check dated 2026-02-04T05:32:15.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    A glossary toggle was added and change highlights were color-coded (green for additions, red for deletions); the revision label was updated to v3.4.0. Older items such as 'No FEAR Act data' and the revision 'v3.3.4' were removed from the history.
    Difference
    0.9%
    Check dated 2026-01-28T03:04:47.000Z thumbnail image
  8. Check
    73 days ago
    Change Detected
    Summary
    The record history now lists Revision: v3.3.4 and removes Revision: v3.3.3. This appears to be a minor site-version update with no impact on the study data or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:01:12.000Z thumbnail image

Stay in the know with updates to Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ociperlimab, Tislelizumab, Chemotherapy in Metastatic NSCLC Clinical Trial page.